<html>
	<head>
		<link href="style.css" rel="stylesheet">
		<title>Your name resume</title>
        <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.4/css/all.min.css">
	</head>

	<body>
		<header id="header">
			<!-- resume header with your name and title -->
			<h1>Sim&oacuten Lizarazo  </h1> 
            <img  class="img-circle avatar" width="200" height="200" src="https://avatars.githubusercontent.com/u/124115449?s=400&u=3089a70e8fd28ff15c617f84a42a9f8d8da2b669&v=4">
			<hr>
			Molecular and Integrative Physiology Ph.D Candidate 
			<hr>
		</header>
		<main>
			<article id="mainLeft">
				<section>
					<h2><b>Contact</b></h2>
					<!-- contact info including social media -->
                    <p>
                        <i class="fa fa-envelope" aria-hidden="true"></i>
                        <a href="mailto:simonl3@illinois.edu">simonl3@illinois.edu</a>
                    </p>
                    <p>
                        <i class="fab fa-github" aria-hidden="true"></i>
                        <a href="github.com/gh-username">slizarazo21</a>
                    </p>
                    <p>
                        <i class="fab fa-linkedin" aria-hidden="true"></i>
                        <a href="https://www.linkedin.com/in/slizarazo/">slizarazo</a>
                    </p>
				</section>
			
				<section>
                    <p>
					<h2><b>Education</b></h2>
                    <h4><i class="fa fa-graduation-cap"></i>Graduate Education</h4>
                    <h3>PhD. Molecular and Integrative Physiology</h3>
                    
                    University of Illinois - Urbana Champaign
                    2019 - Present
                   
                    </p>

					<h4><i class="fa fa-graduation-cap"></i>Graduate Education</h4>
                    <h3>M.Sc Applied Statistics</h3>
                    
                    University of Illinois - Urbana Champaign
                    2022 - Present
                   
                    </p>
                    <h4><i class="fa fa-graduation-cap"></i>Undergaduate Education</h4>
                    <h3>B.Sc Pharmacy</h3>
    
                    Universidad Nacional de Colombia 
                        </p>
                        <p>
                            2012 - 2018
                        </p>
				</section>            
			</article>
			<article id="mainRight">
				<section>
					<h2><b>About</b></h2>
                    I am a PhD Candidate co-advised by <a href="https://nptsai.web.illinois.edu/wp/"> Dr. Nien-Pei Tsai</a> and <a href="https://www.vanbortlelab.com/"> Dr. Kevin VanBortle</a> at  at the University of Illinois at Urbana-Champaign (UIUC). My research interests are focused on the intersection of genomics, statistics, data science, and neurobiology.
					
					<br>
					<br>

					<p>
					Currently I aim to understand the genetic landscape for RNA Polymerase III. My research project aims to build a multi-tissue and cancer atlas of Pol III, uncovering context-specific transcriptional expansion and identification of genes implicated in disease progression. 
					In order to achieve this, I have applied different statistical methods to define significance on genes based on their chromatin accessibility profiles. 
					</p>

					<br>
				

					<p>
				    Maybe you might have not heard too much about Pol III, but the truth is, that this is an amazing enzyme which is totally understudied (Lots of attention of Pol II). Let's share some fun facts about Pol III: 
					
					<br>
					<br>
					<li><i> Pol III is in charge of transcribing a <b>plethora of small non coding RNAs</b>, one of them being tRNAs.</i></li>
					<li><i> Pol III is the <b>largest RNA polymerase protein complex </b> and is comprised of multiple subunits that are either Pol III-specific or otherwise shared with the other polymerases.</i></li>
					<li><i> One of these subunits is POLR3, which has <b>two paralogous subunits</b>: POLR3G which is highly expressed during early development and subsequently attenuated during differentiation and POLR3GL which is expressed at later stages of development and required for long-term survival in vivo.</i></li>
					<li><i> In a cancer context <b>POLR3G expression reemerges. </b>Therefore it is linked with poor outcomes in patients. </i></li>
					<br>
					If you would like to connect, feel free to reach out!
					</p>
			
					<!-- about you -->
					<p></p>
				</section>
				<section>
				
                    </ul>
				</section>
			</article>
		</main>
		<article>
			<section>
				<h2><b>Publications</b > </h2> 
				<ul>
					<li>Cheng R, Zhou S, KC R, <b>Lizarazo S </b>, Mouli L, Jayanth A, Liu Q, VanBortle K (2023). A combinatorial regulatory platform determines expression of RNA polymerase III subunit RPC7α (POLR3G) in cancer. <i>Cancers</i>, 15, 4995</li> <a href="https://www.mdpi.com/2072-6694/15/20/4995"> [Link To Paper]</a>
					<li><b>Lizarazo S</b>, Yook Y, and Tsai NP (2022) Amyloid beta induces Fmr1-dependent translational suppression and hyposynchrony of neural activity via phosphorylation of eIF2α and eEF2. <i>J Cell Physiol</i> 237:2929-2942</li> <a href="https://onlinelibrary.wiley.com/doi/10.1002/jcp.30754/"> [Link To Paper]</a> / <a href="https://mcb.illinois.edu/news/2022-04-26/research-illuminates-balancing-act-protein-linked-fragile-x-syndrome-and-alzheimers"> [News Coverage]</a>
					<li>Liu DC, Lee KY, <b>Lizarazo S</b>, Cook JK and Tsai NP (2021) ER stress-induced modulation of neural activity and seizure susceptibility is impaired in a fragile X syndrome mouse model. <i>Neurobiol Dis</i> 158: 105450 </li>  <a href="https://www.sciencedirect.com/science/article/pii/S0969996121001996?via%3Dihub"> [Link To Paper]</a>
					<li>Liu DC, Soriano S, Yook Y, <b>Lizarazo S</b>, Eagleman DE and Tsai NP (2020) Chronic activation of Gp1 mGluRs leads to distinct refinement of neural network activity through non-canonical p53 and Akt signaling. <i>eNeuro</i> 0438-19.2020</li>  <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218008/"> [Link To Paper]</a>
				</ul>
				<!-- about you -->
				<p></p>
			</section>
		</article>

		<article>
			<section>
				<h2><b>Resources</b > </h2> 
				<ul>
					<li>Cheng R, Zhou S, KC R, <b>Lizarazo S </b>, Mouli L, Jayanth A, Liu Q, VanBortle K (2023). A combinatorial regulatory platform determines expression of RNA polymerase III subunit RPC7α (POLR3G) in cancer. <i>Cancers</i>, 15, 4995</li> <a href="https://www.mdpi.com/2072-6694/15/20/4995"> [Link To Paper]</a>
					<li><b>Lizarazo S</b>, Yook Y, and Tsai NP (2022) Amyloid beta induces Fmr1-dependent translational suppression and hyposynchrony of neural activity via phosphorylation of eIF2α and eEF2. <i>J Cell Physiol</i> 237:2929-2942</li> <a href="https://onlinelibrary.wiley.com/doi/10.1002/jcp.30754/"> [Link To Paper]</a> / <a href="https://mcb.illinois.edu/news/2022-04-26/research-illuminates-balancing-act-protein-linked-fragile-x-syndrome-and-alzheimers"> [News Coverage]</a>
					<li>Liu DC, Lee KY, <b>Lizarazo S</b>, Cook JK and Tsai NP (2021) ER stress-induced modulation of neural activity and seizure susceptibility is impaired in a fragile X syndrome mouse model. <i>Neurobiol Dis</i> 158: 105450 </li>  <a href="https://www.sciencedirect.com/science/article/pii/S0969996121001996?via%3Dihub"> [Link To Paper]</a>
					<li>Liu DC, Soriano S, Yook Y, <b>Lizarazo S</b>, Eagleman DE and Tsai NP (2020) Chronic activation of Gp1 mGluRs leads to distinct refinement of neural network activity through non-canonical p53 and Akt signaling. <i>eNeuro</i> 0438-19.2020</li>  <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218008/"> [Link To Paper]</a>
				</ul>
				<!-- about you -->
				<p></p>
			</section>
		</article>
	</body>
</html>

